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Losing a spouse is considered one of the most stressful life events a person can
experience. Particularly in the immediate weeks and months after the loss, bereavement
is associated with a significantly increased risk of morbidity and mortality. Despite an
abundance of research aimed at identifying risk factors for adverse health outcomes
following marital death, the mechanisms through which mental and physical health
problems emerge following bereavement remain poorly understood. To address this
issue, the present review examines several pathways that may link bereavement
and health, including inflammation and immune dysregulation, genetic and epigenetic
changes, gut microbiota activity, and biological aging. We then describe how these
processes may be viewed from the perspective of the Social Signal Transduction Theory
of Depression to provide a novel framework for understanding individual differences in
long-term trajectories of adjustment to interpersonal loss. Finally, we discuss several
avenues for future research on psychobiological mechanisms linking bereavement with
mental and physical health outcomes.
Keywords: bereavement, interpersonal loss, life stress, inflammation, immune system, biological aging, health,
disease
INTRODUCTION
Losing a spouse can be a very stressful life event that places individuals at risk for mental and
physical health problems (1, 2). Particularly in the immediate weeks and months following spousal
loss, bereavement is associated with increased risk of multimorbidity andmortality (2–5), including
an elevation in inflammation-related health problems (6–10), cardiovascular disease (CVD)
(8, 11–14), and some types of cancer (12). Despite a large body of research in the trauma literature
attempting to identify risk factors for adverse health outcomes following spousal bereavement,
however, the mechanisms through which mental and physical health problems emerge following
interpersonal loss remain poorly understood.
Over the past 30 years, the field of psychoneuroimmunology has helped elucidate how different
life stressors affect autonomic nervous system, neuroendocrine, and immune processes that could
in turn be relevant for understanding the psychobiology of bereavement (15, 16). In particular, the
past decade has produced a substantial body of knowledge shedding light on how specific types of
stressors can trigger increases in inflammation (15, 17–21), which has in turn been linked with the
development of numerous disease conditions, including autoimmune disorders, CVD, and some
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cancers, as well as mortality (12). Consequently, bereavement-
related dysregulation in immune function may be one potential
process that underlies the increased risk for morbidity and
mortality seen in spousal bereaved individuals (22).
One strategy for better understanding the psychobiology of
bereavement involves applying what we know about depression,
which is also strongly precipitated by interpersonal loss. One
model in particular, the Social Signal Transduction Theory of
Depression (20), may be helpful for shedding light on how
spousal loss and grief affect neural and immune processes that
in turn structure risk for health problems following bereavement.
In brief, this theory suggests that both early and later-life stress
can promote neuro-inflammatory sensitivity to subsequently
occurring stressors and thus heighten a person’s vulnerability to
physical and mental health problems across the lifespan. In the
context of bereavement, this would occur if an individual with
a history of past life stress exposure lost a terminally-ill spouse
in adulthood after a sustained period of caregiving burden, in
turn leading to mental and physical health problems that have
an inflammatory basis.
Recently, Knowles et al. (23) published an excellent systematic
review that focused on the link between bereavement and
immune system functioning. The present review also examines
links between bereavement and immune functioning but seeks
to go beyond prior work by providing an integrated account
of psychosocial, neural, immunologic, and genomic processes
linking bereavement and health, as well as a description of
how cumulative lifetime stress exposure may alter vulnerability
to mental and physical health problems following spousal loss.
To accomplish this goal, we conducted a PubMed literature
search of all relevant studies published through October
2019 using the following key words: bereavement, mental
health, physical health, psychobiology, stress, genetic, epigenetic,
neuroendocrine, neuroimmune, inflammation, and immunity.
To be considered for this review, articles had to be peer
reviewed and written in English (see Supplementary Table 1).
The psychometric instruments used in the eligible studies are
summarized in Table 1.
SOCIAL SIGNAL TRANSDUCTION THEORY
OF DEPRESSION
Stressful life events, especially those involving interpersonal
loss, are known to activate several autonomic, neuroendocrine,
and neuroimmune pathways that can lead to increased
inflammatory activity (16), which, if sustained, can increase risk
for inflammation-related physical and mental health problems
(20, 24, 25). Indeed, dysregulation of the immune system is
a critical processes involved in the pathophysiology of various
diseases, including infections, autoimmune diseases, CVD, and
some cancers (19, 26, 27). In addition, inflammatory activity
can negatively affect mental health, and has been found to play
a role in the development of anxiety disorders, post-traumatic
stress disorder (PTSD), and depression (26). In this context, the
cytokines interleukin (IL)-1β (IL-1β), IL-6, and tumor necrosis
factor-α (TNF-α) have been shown to be both upregulated
TABLE 1 | Assessment instruments used in the studies evaluated.
Abbreviation Full name
ATQ-P Automatic Thoughts Questionnaire-Positive version
CSS Crisis Support Scale
CTQ Childhood Trauma Questionnaire
ECR-SF Experiences in Close Relationships Questionnaire-Short Form
GMRI Grief and Meaning Reconstruction Inventory
GMS Grief Measurement Scale
HAMD Hamilton Anxiety and Depression Scale
HRSD Hamilton Rating Scale for Depression
HTQ Harvard Trauma Questionnaire-Part IV
ICG Inventory of Complicated Grief
ICG-R Inventory of Complicated Grief-Revised
IES Impact of Event Scale
LOT Life Orientation Test
MCMI-III Millon Clinical Multiaxial Inventory-III
PSS Perceived Stress Scale
PERI-A Psychiatric Epidemiology Research Interview-Anxiety Scale
PERI-H Psychiatric Epidemiology Research
Interview-Helplessness-Hopelessness Scale
PFQ-2 Personal Feelings Questionnaire-2
PG-13 Prolonged Grief 13 Items
PSOM Positive States of Mind
PSQI Pittsburgh Sleep Quality Index
RPT Relationship Profile Test
SADS-L Lifetime Version of the Schedule for Affective Disorders and
Schizophrenia
SCID-I Structured Clinical Interview for DSM-IV Axis I Disorders
SCL-90 Symptom Checklist-90
SF-36 36-Item Short Form Health Survey
SSI Beck Scale for Suicidal Ideation
STRAIN Stress and Adversity Inventory
TIPI Ten-Item Personality Inventory
TSC Trauma Symptom Checklist
TLEQ Traumatic Life Events Questionnaire
YES Yale Evaluation of Suicidality scale
by interpersonal life stress and associated with poor health
(17, 28–32).
One lingering question in this context has always been
how exactly stressful experiences like interpersonal loss affect
neurocognitive processes that in turn increase inflammation
and inflammation-related disease risk. This important question
is addressed by the Social Signal Transduction Theory of
Depression (20, 33), which is a multilevel theory that describes
neural, physiologic, molecular, and genomic pathways that
link interpersonal stress exposure with internal biological
processes that increase risk for depression and depression-related
health problems. More specifically, this theory hypothesizes
that cumulative lifetime stress exposure, which encompasses
both acute negative life events (e.g., interpersonal loss)
and chronic difficulties, can increase inflammatory activity
through the activation of the autonomic nervous system
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(ANS), hypothalamic-pituitary-adrenal (HPA), and systemic
inflammatory response. Although the temporary engagement of
these systems is critical for survival during times of actual social
or physical threat, sustained activation can occur that increase
a person’s vulnerability to physical and mental health problems
that have an inflammatory component (20, 24, 25, 34, 35).
Consistent with this theory, research has shown that genetic
factors, epigenetic processes, personality traits (e.g., neuroticism),
and social environmental conditions during childhood and
adolescence (e.g., social/financial stress, uncertainty, abuse, or
neglect) play a role in shaping individuals’ sensitivity to later-
occurring adverse life events (25, 36). At the molecular level,
epigenetic regulation of gene transcription can play an important
role in helping individuals adapt to challenges posed by the
external social environmental (37). However, stress-induced
epigenetic changes can also lead to persistent increases in
social stress-related physiological reactivity that last for months
or years (38). In sum, therefore, social-environmental and
genetic processes can independently and interactively affect the
likelihood that a particular adverse life event will get converted
into changes in gene expression that have the ability to influence
health (38, 39).
A growing body of research is showing that the gut microbiota
may also play an important role in shaping the activity of the
enteric nervous system, ANS, neuroendocrine pathways, and
immune system (40). This research has shown that the signaling
pathways linking the central nervous system and gut are sensitive
to social-environmental factors (41). Moreover, disruption of
these systems can result in altered gastrointestinal function, HPA-
axis activation, changes in immune responses, and, therefore,
increased inflammation-related behavioral changes and disease
susceptibility (42, 43).
In sum, the Social Signal Transduction Theory of Depression
provides one illustration of how interpersonal loss can lead
to specific changes in sympathetic nervous system (SNS) and
HPA-axis activity that interact with genetic, personality, and
social-environmental factors to promote immune dysregulation
and increased inflammatory activity, especially in vulnerable
individuals. These biological changes can in turn lead to
depression-like behaviors, including anhedonia, helplessness,
social withdrawal, and fatigue (26), which are characteristic
of some bereaved individuals, thus making the Social Signal
Transduction Theory of Depression a potentially useful
framework for understanding psychosocial and biological
aspects of bereavement (see Figure 1).
PSYCHOBIOLOGY OF BEREAVEMENT
FROM THE PERSPECTIVE OF SOCIAL
SIGNAL TRANSDUCTION THEORY OF
DEPRESSION
For the purpose of this review, the term grief and bereavement
have been conceptualized with slightly different meanings.
Whereas, grief refers to a person’s emotional response to a
loss, bereavement refers to the time period when an individual
experiences sadness, grief and mourning after a significant loss.
Typically, bereavement is the period during which time the most
intensive grieving occurs (44).
The loss of a significant person in one’s life is a unique
social stressor that requires an individual to adapt, which
differentiates it from other stressors such as caregiving, a
conflictual marital relationship, or unemployment (45). To better
understand psychological adjustment to significant interpersonal
loss, research has employed concepts from the literatures on
attachment theory, cognitive processing, and resilience. Early
life attachment has been proposed to impact relationships in
adulthood (46). In this regard, the loss of a spouse represents
an attachment stressor that inherently has physiological effects,
as attachment stress evolutionarily served to maintain proximity
between bonded pairs (23).
As a highly stressful event, the death of a significant
person is known to trigger biological responses via several
autonomic, neuroendocrine, and inflammatory pathways (22).
These responses, either directly or via interaction with the social
environment, can cause alterations in biological functioning that
include the onset of chronic low-grade inflammation, which
can increase risk for sickness behaviors, infections, mental and
physical health problems, and premature mortality in vulnerable
individuals (26, 47–49). Consistent with this thinking, several
lines of evidence indicate that stressful life events are strongly
associated with altered immune function and the development
of depression, especially for persons living in a high-risk
environment (e.g., trauma exposure) who possess a genetic
predisposition to depression (20, 50–52). Moreover, clinical
studies have shown that depressive symptoms are prevalent in
widows and widowers during the first 2 years of bereavement,
with a particular high risk for individuals with a history of
depression (53, 54). To the extent that grief and depression
are precipitated most strongly by the same types of major life
stressors (i.e., sudden interpersonal loss), it may be possible to
apply what we know about the psychobiology of depression (e.g.,
using the Social Signal Transduction Theory of Depression) to
better understand the psychobiology of bereavement.
Importantly, the grief response depends on the nature
and quality of the lost relationship (55). For example, the
unintentional death of a spouse will be experienced differently
than the death of a child, parent, or sibling, or the death of a
close other by suicide (56). Furthermore, the unexpected death
of a loved one may trigger different grief reactions than the
loss of a spouse due to a terminal disease (56, 57). Hence,
the psychobiology of bereavement may differ depending on the
specific types of loss experienced (58). In the present article,
therefore, we focus specifically on spousal bereavement as a
particular type of life stressor.
In the following sections, we examine the applicability of the
Social Signal Transduction Theory of Depression for studying
psychobiological pathways that may link bereavement with
multimorbidity and mortality. To do this, we review available
research describing the impact of spousal loss on (a) mental and
physical health, (b) inflammation and immune dysregulation, (c)
genetic and epigenetic changes, (d) gut microbiota activity, and
(e) biological aging. We also describe the effects of cumulative
life stress exposure on health in bereaved individuals and explore
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psychobiological factors that have been linked to vulnerability
and resilience to mental and physical health problems following
significant interpersonal loss. Finally, we discuss how Social
Signal Transduction Theory of Depression can be extended to
bereavement and highlight several avenues of research that may
be fruitful to pursue on this topic.
The Impact of Bereavement on Mental
Health
As alluded to previously, the death of spouse is one of the
most stressful life events a person can experience (59). Spousal
bereavement due to cancer, for example, is usually preceded
by a long illness trajectory, which is associated with high
distress due to the spouse’s progressive health deterioration,
anticipatory grief about the spouse’s inevitable death, adoption of
supportive responsibilities, financial stressors, and disruption of
the caregiver’s social and personal life (60). Moreover, partners
of patients who have been suffering from an advanced illness
have been found to experience more emotional distress and
adjustment problems, as well as greater pain, fatigue, sleep
problems, and depression (61–65).
There is considerable variability in how people respond to
the loss of a spouse. For example, although the vast majority
of conjugally bereaved individuals are relatively resilient and
adjust adequately without professional support (66, 67), 10–
20% of bereaved spouses develop intense, prolonged grief (67–
69). In addition, substantial evidence suggests that high levels
of traumatic grief, depression, and anxiety at 6 months post-
loss predict the development of even more serious mental and
physical health problems up to 25 months post-loss in spousal
bereaved individuals, including suicidal ideation, cancer, and
heart attacks (70).
Grief is a typical psychological and emotional reaction to
losing a significant person that is characterized by symptoms
of intense distress, anxiety, yearning, longing, and sadness, all
of which usually subside over time (71). Although grieving
symptoms are similar in some ways to symptoms of Major
Depressive Disorder (MDD), as described by the Diagnostic
and Statistical Manual of Mental Disorders (DSM-5), these
two conditions are classified as distinct constructs (72, 73).
Prolonged or persistent grief, by definition, is a debilitating
condition following a significant loss that consists of persistent
and pervasive longing for, or preoccupation with, the deceased
person that persists for 6 months or longer. Moreover, it is
characterized by its clinical features, including emotional pain
(e.g., sadness, guilt, bitterness, anger), difficulty accepting the
loss, emotional numbness, feeling that a part of one died, and
difficulties in engaging in social or other activities (69). The
diagnostic criteria for prolonged grief reactions are specified in
the DSM-5 as Persistent Complex Bereavement Disorder (PCBD)
(74) and in the International Statistical Classification of Diseases
11th Revision (ICD-11) as Prolonged Grief Disorder (PGD)
(75, 76). PGD can be diagnosed at 6 months and PCBD at 12
months following the loss (77).
Bereavement is associated with short- and long-term health
consequences. In one study that examined the early bereavement
period (i.e., 6 months post-loss), prolonged grief was found in
12.3% of 56 bereaved adults between 20 and 50 years old who lost
their spouse due to cancer (78). In another study of 132 adults,
almost 30% of bereaved adults who lost a close relative to cancer
met criteria for post-traumatic stress disorders 1 month post-
loss (79). Over the long term, complicated grief was found to be
present in 24.6% of 668 cancer caregivers 9months post-loss (80),
and 48% of 88 cancer caregivers who suffered from increased
levels of bereavement-related distress 3–5 years after the loss (81).
As briefly noted above, high levels of prolonged grief
symptoms have been associated with greater disability and can
compromise psychological and physical functioning for years,
resulting in comorbid health problems. These health problems
include impaired sleep (82, 83), depression (9, 84–86), suicidal
ideation and attempts (12, 87), and anxiety and PTSD (88,
89), as well as adverse health behaviors (12), prolonged sick
leave, and increased health services and medication use (90–92).
Furthermore, grief severity assessed from 3 to 6 months post-
loss has been found to predict functional impairment, depressive
symptoms, and impaired sleep up to 18months following the loss
(86, 93).
Of note, depression, and bereavement share considerable
commonalities in terms of disease risk (e.g., CVD) and changes
in immune function (2, 6, 11, 94–97). Some researchers have
thus suggested that it is not interpersonal loss or bereavement
but rather depression that is responsible for causing the increases
in morbidity and mortality seen in bereaved individuals (9, 12,
49, 89, 98). On the other hand, though, research has shown that
grief and depression are independently associated with health-
damaging inflammation (99). Therefore, it may be the case
that bereavement and depression are associated with similar but
distinct patterns of inflammatory activity, and that interpersonal
loss is a common precipitating stressful life event that may lead
to both grief and depression.
The Impact of Bereavement on Physical
Health
Bereavement has also been found to increase individuals’ risk
for physical health problems and, especially, immune-related
illnesses such as CVD and cancer, in addition to increased
mortality risk, within the first 3 years following a major loss
(12, 92). Indeed, CVD is a major cause of morbidity and
mortality following bereavement (100). In terms of underlying
mechanisms, strong evidence has linked bereavement-related
stress with increased risk for CVD via chronic low-grade
inflammation, as commonly measured by circulating IL-6 or C-
reactive protein (CRP) (27, 101, 102). In addition, elevated levels
of CRP have been shown to be a strong prognostic factor for
atherosclerosis and cardiovascular events (103, 104).
In terms of mortality risk, a meta-analysis of 15 prospective
cohort studies and 2,263,888 participants found that relative
to their married peers, recently bereaved spouses had a 41%
increased risk of dying within the first 6 months following
bereavement, independent of age and gender (overall RR 1.41;
95%CI 1.26, 1.57) (105). Another meta-analysis of more than 500
million people found a 23% increased risk of mortality among
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FIGURE 1 | Psychobiological mechanisms linking spousal bereavement and health from the perspective of the Social Signal Transduction Theory of Depression (20).
The interplay between genetic factors, personality traits (e.g., neuroticism), and social-environmental conditions during childhood and adolescence (e.g.,
social/financial stress, uncertainty, abuse, or neglect) are hypothesized to play important roles in shaping individuals’ neuro-inflammatory sensitivity to later-occurring
life stressors, including interpersonal loss. Exposure to early life stress and subsequent stressors are hypothesized to heighten sympathetic nervous system and
hypothalamic-pituitary-adrenal axis dysregulation, and to promote increased inflammatory activity in response to a significant loss. If chronic, elevated inflammatory
activity can in turn lead to a variety of adverse emotional, behavioral, and health outcomes. SNS, sympathetic nervous system activation; NE, norepinephrine; EPI,
epinephrine; HPA, hypothalamic-pituitary-adrenal; GC, glucocorticoid; IL-1, interleukin-1; IL-1β, interleukin-1beta; IL-6, interleukin-6; IL-6R, interleukin-6 receptor;
IL-12, interleukin-12; TNF-α, tumor necrosis factor-α.
widowers as compared to married individuals (HR 1.23; 95% CI
1.19, 1.28), with a relatively higher risk for men (increased risk:
27%) than women (increased risk: 15%) (3). This phenomenon
of increased mortality risk for bereaved individuals, specifically
within the first 6 months after the interpersonal loss, has been
called the “broken-heart phenomenon” (106) or “widowhood
effect” (105). Nowadays, these terms have also been used in the
context of Takotsubo cardiomyopathy, an acute reversible heart
failure syndrome mimicking acute myocardial infarction that is
frequently triggered by emotional stress, including loss and grief
(107, 108).
Depression and stress are important risk factor for developing
CVD, and depression has been associated with poorer coronary
outcomes (94). Correspondingly, the death of a significant person
is known as a key psychosocial risk factor for CVD (11). Research
has shown that as compared to non-bereaved individuals,
bereaved individuals exhibit lower heart rate variability and
higher heart rate, systolic blood pressure, von Willebrand factor,
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factor VIII, and platelet/granulocyte counts (6, 8, 13, 109,
110). These findings have direct clinical relevance, given that
prothrombotic changes have been associated with greater risk of
CVD and mortality (111, 112). Of note, the adverse effects of
stress on cardiovascular and other outcomes are often potentiated
by unhealthy behaviors, including poor dietary choices and sleep
hygiene, inadequate physical activity, alcohol and/or tobacco
consumption, and poor medication adherence (113), all of which
are risk factors for CVD in their own right.
Regarding the implications of bereavement for cancer
risk, stress hormones, especially glucocorticoids, adrenaline,
and noradrenaline, have multiple known effects on human
tumor biology (114, 115). Specifically, SNS activation via
adrenergic- and glucocorticoid-mediated mechanisms can
increase inflammatory activity and alter immune defense
mechanisms against tumors with implications for tumor
progression (116). Consistent with these pathways, a few
studies have suggested that bereavement is associated with
increased risk for cancer incidence. For example, a historical
study conducted by Prigerson et al. (12) found that bereaved
individuals suffering from high levels of grief had a significantly
greater risk of developing cancer within 6–25 months post-loss
than those with low levels of grief, yet the type of cancer
was not described. Additionally, the Pan American Health
Organization/World Health Organization examined the effects
of parental bereavement on cancer incidence and survival (117).
This large cohort study included 6,284 Jewish Israelis who
lost an adult son in the Yom Kippur War or in an accident
between 1970 and 1977, and who were followed longitudinally
for 20 years. There was an increased incidence of lymphatic
and hematopoietic malignancies in both war-bereaved parents
(OR 1.47) and parents of accident victims (OR 2.01). There
also was an increased incidence of melanoma among both
war-bereaved parents (OR 1.72) and parents of an accident
victim (OR 4.62). Finally, in parents suffering from cancer before
the loss, bereavement was associated with a relatively shorter
survival time.
These data highlight a possible association between
bereavement and cancer. Consistent with this work, data
from the psycho-oncology literature suggest that the incidence
of cancer recurrence may be higher during bereavement-related
distress (114–116, 118–122). On the whole, though, the available
evidence linking bereavement and cancer risk is not highly
consistent and is certainly limited relative to the relatively large
amount of research demonstrating an association between
bereavement and CVD risk.
Another condition associated with bereavement is type 2
diabetes, a chronic metabolic disorder characterized by insulin
resistance due to insufficient insulin secretion and action (123).
A growing body of research indicates that stress plays a role in
type 2 diabetes, both as a predictor of new-onset type 2 diabetes
and as a prognostic factor for individuals with existing type 2
diabetes. Stress-related biological pathways that are believed to
contribute to the pathogenesis of type 2 diabetes include chronic
activation of the HPA axis, which can result in neuroendocrine
dysfunction and dysregulated cortisol output (123) that leads to
glucose intolerance and systemic insulin resistance (124).
Only a limited number of studies have investigated the onset of
type 2 diabetes in the context of bereavement. One study reported
a 1.4-fold increased risk of incident diabetes in parents who
lost their child relative to age- and sex-matched non-bereaved
parents (125). Another study found that bereavement-induced
prenatal stress in mother increased the risk of insulin resistance
by 1.3-fold in their offspring; if grief was due to the death of
an older sibling, the risk that the offspring developed type 2
diabetes during childhood or young adulthood was increased by
1.5-fold (126).
Taken together, these data provide relatively strong
converging evidence that bereavement is associated with
increased risk for poor mental and physical health. In most cases,
the mechanisms underlying these bereavement-related health
effects remain unclear. To address this issue, in the following
sections we review psychoneuroimmunological pathways that
may link bereavement with mental and physical health problems.
We also discuss how these effects may be understood through
the lens of the Social Signal Transduction Theory of Depression.
PSYCHOBIOLOGICAL MECHANISMS
LINKING BEREAVEMENT AND HEALTH
Bereavement-Induced Systemic
Inflammation and Immune Dysregulation
Neuroendocrine, Sympathetic, and Inflammatory
Activation
Several psychological, neural, and immunologic pathways may
link bereavement with health. For example, it is well-known that
stress activates the HPA axis and sympathetic-adrenal-medullary
(SAM) axis, which in turn trigger the release of hormones that
modulate immune function. Specific hormones involved in this
stress-induced biological cascade include adrenocorticotropic
hormone (ACTH), cortisol, growth hormone, prolactin,
adrenaline, and noradrenaline (15). Through these mediators,
life stress exposure can increase inflammatory activity and
reduce anti-viral immune responses (17, 127).
In the context of bereavement, studies have begun to
explore bereavement-related alterations in biomarkers of
neuroendocrine and immune function. Results from these
studies show that within the first 6 months following spousal
loss, bereaved individuals exhibit evidence of reduced antibody
response to vaccination (128), HPA-axis dysregulation [e.g.,
as indexed by higher cortisol levels and flatter diurnal cortisol
slopes (9, 59, 129–132)], heightened systemic inflammation
(6, 10, 49, 99, 133), and impaired immune responses, as indexed
by reduced functional activity of natural killer cells (9, 130).
Research has also suggested that these bereavement-related
biological alterations, particularly those involving inflammation,
may underlie the development of complicated grief. For
example, in a recent study of 99 spousally bereaved individuals
by Fagundes et al. (99), bereaved individuals with greater
grief severity and higher levels of depression showed higher
levels of the pro-inflammatory cytokines interferon gamma
(INF-γ), IL-6, and TNF-α approximately 3 months after the
death of their spouse as compared to those who had more
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mild emotional reactions to the loss. Sleep disturbances can
also induce inflammation (134). In a study of 54 spousally
bereaved and 47 non-bereaved individuals, self-reported
sleep disturbance in bereaved individuals was not directly
related to elevated inflammatory activity, but bereavement
moderated the association between sleep disturbances and
inflammation approximately three moths post-loss, after
adjusting for depression (133). Therefore, sleep disturbance may
be an important pathway linking bereavement with increased
inflammation and subsequent health problems.
Mechanistically speaking, the pro-inflammatory cytokines IL-
1β, IL-6, and TNF-α are believed to influence the activity of
neurotransmitters that can in turn affect mood and induce
depressive symptoms in vulnerable individuals (28, 135).
Consistent with this understanding, some studies have argued
that changes in immune function and related neurochemical
processes during bereavement are the result of bereavement-
related depression as opposed to experiencing interpersonal loss
or bereavement (136). Therefore, additional research is needed
to examine the extent to which the increased inflammatory
levels sometimes evident during or following bereavement are
the result of an intense bereavement period itself vs. increases in
depressive symptoms that sometime accompany bereavement.
Immune Dysregulation
Bereavement may also affect health by influencing immunity.
Immunity is the natural or acquired resistance of an organism
to bacterial or viral invaders, diseases, or infections, while
having adequate tolerance to avoid allergy and autoimmune
diseases (18). Lymphocytes, including T cells and B cells, as
well as natural killer (NK) cells and macrophages, are the main
types of cells of the immune system. T cells orchestrate the
immune response via the production of cytokines and stimulate
B cells to produce antibodies and signal killer cells to destroy
antigen-displaying cells (137). Chronic stress, in turn, can induce
low-grade inflammation and suppress immuno-protective cell
function (18).
Studies investigating immune function in bereaved
individuals have demonstrated NK cell activity suppression
for up to 6 months following the sudden death of a relative
(9, 130), lymphocyte proliferation for up to 2 months following
spousal loss (138), and downregulated leukocyte gene expression
in individuals who lost their spouse over the prior 2 years
as compared to non-bereaved healthy adults (139). Seasonal
influenza vaccination provides a useful paradigm to study
individual differences in the inflammatory response. In one
study that used this immunological challenge model in the
context of bereavement, bereaved adults exhibited a reduced
antibody titer response to influenza vaccination 1 year post-loss
relative to non-bereaved adults (128). Together, these findings
illustrate how bereavement can lead to long-lasting impairments
in immunity that have implications for health.
Bereavement-Induced Genetic and
Epigenetic Changes
Another pathway by which bereavement may influence health
is by affecting genetic and epigenetic pathways. Early life stress
exposure has been associated with heightened physiological
stress sensitivity as indexed by inflammatory activity and
reactivity, as well as with greater immune system dysregulation
later in life (30, 47, 140–143). In terms of gene expression,
stress-induced epigenetic changes can result in altered gene
expression (38).
The fields of psychoneuroimmunology, genetics, and
genomics have only recently begun to examine genomic
mechanisms that may underlie these effects. Although the
literature examining bereavement-associated epigenetic changes
remains scant, this research has already provided an interesting
new window through which we may be able to better understand
how bereavement affects health (34, 144). In this context,
a few genetic polymorphisms have been investigated that
could represent potential protective or risk factors in the face
of adversity. For example, one recent cross-sectional study
investigated the gene × environment (G × E) interaction effects
of different genotypes and inflammation for 36 spousal bereaved
older adults who experienced spousal loss over the past 23.75
months vs. 28 married individuals in order to elucidate factors
predicting resilience during bereavement. The researchers found
that spousally bereaved individuals exhibited higher levels of
circulating inflammatory markers relative to non-bereaved
individuals. Moreover, the authors identified a SNP in the
IL-6-174 region that moderated individuals’ vulnerability to
increased systemic inflammation following the death of their
spouse (49).
Relatedly, a cross-sectional study by O’Connor et al. (139)
identified a genotype that helped explain the variability in
grief severity experienced by older adults with and without
complicated grief following the death of their partner or spouse.
Individuals with both complicated grief (N = 12) and non-
complicated grief (N = 24) exhibited the upregulated expression
of genes implicated in the activation of the immune response and
downregulated expression of genes implicated in B lymphocyte
responses. Moreover, individuals exhibiting complicated grief
showed a substantial downregulated expression of Type I
interferon transcripts.
It is possible that mutations in these genes may lead to
the altered regulation of pro- and anti-inflammatory cytokine
gene expression, in turn placing individuals experiencing
bereavement-related distress at increased risk of experiencing
immune-related health problems following bereavement (26).
Furthermore, changes in gene expression following bereavement
may interact with epigenetic changes that have occurred earlier
in life (e.g., from early life stress exposure) to influence how an
individual responds to the loss of a spouse in later adulthood.
Likewise, bereavement itself may cause epigenetic changes that
could increase a person’s risk of subsequent health problems
through the activation of the previously described inflammatory
pathways (34).
Together, these data suggest that increased inflammatory
activity may predominantly occur in genetically susceptible
individuals who experience the loss of a significant person.
This G × E effect may provide a possible mechanism through
which bereavement-related stressors increase vulnerability for
morbidity andmortality in bereaved individuals. The G× E effect
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may also help explain why some bereaved individuals develop
mental and physical health problems following the death of a
spouse while others do not.
Bereavement-Induced Changes in the Gut
Microbiota
In addition, the gut microbiota may play a role in influencing
health outcomes following bereavement. Evidence for this
possibility comes from research documenting how acute and
chronic stressors negatively impact the gut microbiome (41).
Animal models provide experimental evidence for associations
between early life stress exposure and low-grade inflammation,
altered enteric microbiota, exaggerated stress reactivity, and
visceral hypersensitivity (42, 145), emphasizing the impact of
stress on microbial composition and activity. In humans, it
is well-known that stress can cause nausea, vomiting, and
abdominal pain (146). In addition, chronic life stressors such as
financial problems, unemployment, and loss have been associated
with an increased risk of developing functional gastrointestinal
disorders, such as irritable bowel syndrome (147, 148). Moreover,
accumulating evidence from clinical studies suggests a strong link
between stress-induced disturbances along the gut microbiota-
immune-brain axis and chronic inflammatory disorders, such
as allergies, autoimmunity, and inflammatory gastrointestinal
disorders (149, 150), and mental health problems including
anxiety disorders and depression (151–155).
In contrast with this general body of research on stress and
the gut microbiota, only a few studies to date have investigated
how stress may lead to changes in the gut microbiota in
the context of bereavement. Moreover, much of the research
examining the effects of stress on the gut microbiota is still
from animal model studies (43). Therefore, the American
Gastroenterology Association and American Psychosomatic
Society have encouraged efforts to characterize pathways linking
stress and the gut microbiota-immune-brain axis in large,
prospective, longitudinal cohort studies to better understand
microbiome composition and microbial function in healthy and
diseased individuals (156). Ultimately, it is possible that stress
may change microbiota and vice versa via neuroendocrine (157),
inflammatory (158), and behavioral (e.g., depression) pathways
(154), but additional research is needed on this topic in general
and especially in the context of bereavement.
Bereavement and Biological Aging
Bereavement may also affect health through stress-induced
accelerations in biological aging as indexed, for example,
by telomere length. Telomeres are short DNA sequences
that are located on the end of chromosomes. Telomeres
protect chromosomes from degradation by forming a cap that
provides chromosomal stability. Telomeres also regulate cellular
replication and cellular lifespan (159). Of clinical importance,
telomere length shortens with age (160), and extensive research
has also shown that accelerated shortening of telomeres is
associated with premature cell death, senescence, apoptosis, and
carcinogenesis, in turn increasing morbidity and mortality (161).
Furthermore, there is emerging evidence for an association of
chronic stress with greater oxidative stress, lower telomerase
activity, and shorter telomere length, indicating that stress may
contribute to accelerated biological aging, thus providing a
possible mechanism linking stress with health (39, 159, 162, 163).
Telomere attrition has emerged as a potentially useful
biomarker of cellular aging that has shown associations with
increased risk of various diseases and poorer survival (164).
Additionally, the long-term effects of bereavement-related stress
have been demonstrated in a study that investigated the impact
of death or a sudden severe illness of a close family member
during prenatal development. The study found that young
adults with mothers who had experienced a death during
prenatal development had shorter leukocyte telomere length as
compared to young adults with mothers who had a pregnancy
without experiencing death (165). These findings are of clinical
importance for two reasons: first, telomere length in newborns
and young adults has been related to maternal stress during
pregnancy; and second, cellular aging can be influenced through
prenatal stress, thereby potentially increasing an individual’s
susceptibility to infectious and autoimmune diseases in later life
(166, 167).
Moreover, biological aging can affect the immune system
by causing a progressive decline in functional immunity,
referred to as immunosenescence, which diminishes humoral and
cellular immune responses. Immunosenescence typically occurs
in older individuals (≥65 years old) (168, 169). Declining T-cell
function is a well-characterized feature of immunosenescence,
contributing to chronic low-grade inflammation (170). However,
chronic stress also has been shown to suppress and dysregulate
immune function via immunosenescence (162). Consequently,
age-associated declines in immune function can contribute to
many comorbid conditions and may render older individuals
more vulnerable to further assaults on their immune system
from things like stress, immune-related illnesses, and infectious
diseases (171). For instance, systemic low-grade inflammation, as
indexed by circulating levels of CRP and IL-6, has been identified
as a significant risk factor for CVD in elderly individuals (102).
The loss of a spouse or partner occurs most frequently in
later life and is thus a life event that is often experienced by
individuals older than 65 years, mainly due to the loss of a
spouse (172). Several studies have found evidence of reduced
immunity in older adults who have experienced bereavement.
For instance, older bereaved vs. non-bereaved individuals with a
mean age of 75 years have been found to show a weaker antibody
response to vaccination in the year after the loss of a spouse
(128). Furthermore, older bereaved individuals (Mage = 72 years
old) have been found to exhibit impaired neutrophil function,
lower neutrophil reactive oxygen species (ROS) production, and
a higher cortisol-to-dehydroepiandrosterone sulfate (DHEAS)
ratio relative to younger adults (Mage = 32 years old) (173,
174). Of note, cortisol is generally immunosuppressive, whereas
DHEAS (secreted by the adrenal gland) is immune-enhancing
and counterbalances the effects of cortisol on the innate immune
system (175). With aging, though, cortisol and DHEAS respond
differently to stress, resulting in a negative regulatory effect on
immune function (173).
In addition, from a molecular perspective, older bereaved
adults (aged 61–83 years old) have been found to show the
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reduced expression of genes involved in the B lymphocyte
immune response as compared to a sample of age- and sex-
matched non-bereaved adults (139). The salient incidence of
immune-related dysregulation in older bereaved individuals
suggests a pivotal role of mutually enhancing effects of
stress and inflammation on immunosenescence (176). Indeed,
bereavement-related distress may promote a natural decline
of the immune system and increase older adults’ risk of
bereavement-related morbidity and mortality (177).
Cumulative Life Stress Exposure and
Bereavement
Chronic stress, especially when experienced in early life, can also
affect health outcomes in bereaved individuals by setting the stage
for long-lasting neurobiological changes that are associated with
increased risk of later morbidity and mortality (178). Specifically,
stress exposure during childhood can alter behavioral and
physiological responses to acute and chronic stress in adulthood
that in turn influence later-life risk for mental and physical health
problems, including anxiety disorder, depression, CVD, and
autoimmune and neurodegenerative disorders (20, 39, 47, 140,
179). Epigenetic changes and immune system dysregulation may
be potential pathways that underlie this link (36, 39, 180). Indeed,
the presence of multiple childhood adversities has been found to
heighten emotional and physical reactivity to subsequent stress,
which in turn activates genetic and epigenetic processes that may
promote a proinflammatory phenotype (20).
In addition, cumulative life stress exposure is an important
moderator of the association between acute life events, such as the
loss of a spouse, and vulnerability to mental and physical health
problems. As proposed by the Social Signal Transduction Theory
of Depression, for example, greater lifetime stress exposure
can increase neuro-inflammatory sensitization to adversity that
increases a person’s risk for immune-related mental and physical
health problems in the face of subsequent interpersonal loss
(20). Consistent with this formulation, among individuals with a
history of childhood maltreatment, those who have experienced
spousal loss have been found to be more likely to develop
depressive symptoms than those who have not experienced
such loss (84). These results suggest that adverse childhood
experiences may set the stage for experiencing worse immune-
related health outcomes following a significant loss in adulthood.
Psychosocial Factors Affecting Risk and
Resilience in Bereavement
Finally, several psychosocial factors can affect risk and resilience
for poor health following bereavement. Resilience to stress is
characterized by an individual’s ability to maintain or restore
relatively stable psychological and physical functioning when
confronted with stressful life events, such as the death of a spouse
(181). It has been hypothesized that resilience to such stressors
arises from a combination of genetic factors (e.g., regulatory
SNPs), personality traits (e.g., neuroticism, rejection sensitivity),
and social-environmental conditions (e.g., life stress exposure,
socioeconomic status) (182).
Bonanno et al. have conducted several seminal studies
to better understand mechanisms underlying resilience (66,
181). For example, analyzing prospective longitudinal data
from individuals enrolled prior to the death of a spouse,
these investigators have identified four prototypical grieving
trajectories: resilience (66.3%) and chronic depression (14.5%),
followed by depressed improved (10.1%), and chronic grief
(9.1%) (183, 184). Contrary to expectations, for most individuals
(∼60%), grief subsided over the initial weeks and months
following the loss, indicating that most people are relatively
resilient to interpersonal loss (184). However, even among
resilient individuals, a majority showed grief reactions as
characterized by transient distress, emotional pain, yearning,
intrusive cognition, and rumination (185). In turn, only a small
subgroup of grieving individuals exhibited severe grief that
persisted for years after the marital loss (183, 184).
Psychosocial factors that appear to help buffer the negative
effects associated with interpersonal loss include social support
(186–188), secure attachment style (46, 189), positive emotions
(129, 188, 190), optimism (191), cognitive flexibility (including
positive reappraisal and acceptance) (192), and spirituality,
including religiosity (193). In contrast, there are numerous
psychosocial factors that have been found to weaken resilience to
loss and grief, contributing to grief severity and prolonged grief
reactions. These risk factors include the characteristics of spousal
death [e.g., context of spousal illness, caregiving strain, lack of
preparation for the death, traumatic loss (67, 194)], relationship
quality [e.g., close kinship relationship, affection, intimacy,
care, understanding, conflicts, ambivalence, and dependency in
relationship (67, 195)], intrapersonal factors [e.g., extraversion,
neuroticism, insecure, anxious or avoidant attachment styles,
poor emotion regulation, negative cognition, pre-loss depression
(67, 196, 197)], and interpersonal factors [e.g., low social and
emotional support, financial hardships (67)].
In the bereavement literature, most studies that have been
conducted so far have investigated group differences or correlates
of bereavement, and only a few have examined biomarkers of
resilience and vulnerability for bereavement-related morbidity.
In this context, Buckley et al. (6) examined predictors of
increased risk for thrombotic changes that might contribute to
cardiovascular risk in the initial weeks following the death of a
spouse and found a potential role for neutrophils, vonWillebrand
factor antigen, Factor VIII, and platelet/monocyte/granulocytes.
Smoking was associated with a higher neutrophil count in
acutely bereaved individuals and accounted for 6% of the shared
variance (r2 = 0.06, p= 0.02). Moreover, duration of relationship
between spousal bereaved and deceased spouse (p = 0.03) and
smoking (p = 0.001) were found to be associated with higher
platelet/granulocyte aggregate levels, accounting collectively for
14% of shared variance (r2 = 0.14).
In addition to this research, two studies have examined
changes in immune function following spousal loss while
differentiating between grief severity and depression. The
first study by Fagundes et al. (99) found that grief severity
and depression were independently associated with increased
systemic inflammation (e.g., IL-6, TNF-α, IFN-y) in bereaved
individuals approximately 3 months following the loss of a
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spouse. Furthermore, in the same study, MDD was a significant
predictor of participants’ levels of the proinflammatory cytokines
IL-6, TNF-α, INF-γ, and IL-17A following spousal loss. Contrary
to expectation, depression did not moderate the association
between grief severity and inflammation. Likewise, a second
study identified fatigue (as indexed by the SF-36 Energy/Fatigue
sub-score) as a predictor of low-grade inflammation (as
measured by CRP) in bereaved individuals 1 month following the
loss of a spouse (10).
In general, these findings documenting psychosocial
factors associated with risk and resilience in bereavement are
preliminary and require replication to determine their reliability
and relevance for predicting vulnerability to bereavement-related
morbidity. Furthermore, most of the studies in this area have
used cross-sectional, post-interpersonal loss research designs.
Studies that include pre-loss measures of neuroendocrine and
immune biomarkers, and that follow participants over time, are
therefore needed.
DISCUSSION
Bereavement From the Perspective of the
Social Signal Transduction Theory of
Depression
As discussed at the beginning of this review, we believe that
psychobiological processes linking bereavement and health can
be viewed from the perspective of the Social Signal Transduction
Theory of Depression in order to provide one possible
framework for better understanding processes that may underlie
individual difference in risk and resilience to interpersonal
loss. More specifically, the Social Signal Transduction Theory
of Depression describes neural, physiologic, molecular, and
genomic mechanisms linking interpersonal loss and health, as
well as several moderators that can influence the effects of life
stress on immune function and health, such as age, sex, and early
life, adulthood, and cumulative lifetime stress exposure. Another
important feature of the theory is that it differentiates between
different types of life stressors and also accounts for individual
characteristics—including both personality and genetic traits—
that may render an individual differentially susceptible to the
negative effects of stress and bereavement. Insights from this
theory may thus help to address several existing questions in the
bereavement literature, including why some individuals are more
resilient than others to interpersonal loss, why cumulative life
stress exposure is a strong predictor of morbidity and mortality
in bereaved individuals, and why bereavement is associated with
an increased risk of experiencing physical health problems. In
light of this, we believe that identifying how social and biological
factors identified by this theory might help explain differences in
bereavement severity and persistence is an important topic for
future research.
Integrating the consequences of the loss of a significant
individual into the Social Signal Transduction Theory of
Depression seems to be feasible with some modifications. For
example, the Social Signal Transduction Theory of Depression
emphasize that stressors experienced over time and exert a
cumulative effect on neural and immunologic functioning that
sensitizes a person to future stressors, such as interpersonal
loss. In this model, the death of a loved one is regarded as
a unique, complex stressor that can involve several types of
adversity, including housing difficulties, financial strain, physical
relocation, retirement, and the loss of daily routines andmeaning
in life (198, 199).
Relative to other topics in psychoneuroimmunology, the grief,
loss, and bereavement literature has generated very few data
documenting how lifetime stress exposure affects psychological,
neural, and immunologic outcomes in bereaved individuals over
time. It is possible that the severity or taboo of discussing grief
has rendered the investigation of mental and physical health
problems following spousal bereavement difficult. Moreover,
obtaining funding for studies designed to examine health
outcomes among bereaved individuals (as opposed to patients)
can be difficult. As a result of these factors, despite the great
importance of this topic, the health consequences of bereavement
remain poorly understood (200, 201).
FUTURE DIRECTIONS
To better understand how bereavement affects health, we believe
there is a pressing need to study how bereavement leads to
changes in psychological, neural, and immunologic functioning.
Biobehavioral responses to grief, epigenetic changes, cumulative
life stress exposure, and neural sensitivity to stress could each
represent potential mechanisms linking bereavement and health.
Therefore, it will be important to adopt a multidimensional
approach to studying bereavement that involves assessing how
these and other processes interact and change over time to
structure differences in disease risk and longevity in the context
of bereavement. Below, we discuss several direction for future
research along these lines.
First, the early identification of individuals who are at the
greatest risk of experiencing poor health outcomes following the
death of a significant person is an important aim of precision
medicine and disease prevention initiatives (202). Encouraging
bereaved individuals to provide mental health and biological
data will help advance research on how bereavement impacts
mental and physical health. This knowledge can in turn help
prevent or treat mental and physical health problems in bereaved
individuals, especially those deemed to be at high risk as a
function of their psychosocial or biological status. Ultimately,
identifying biobehavioral mechanisms that can be modified or
targeted early on in the bereavement process is an important and
clinically relevant step toward the development of treatments that
improve health outcomes in bereaved spouses.
Second, additional research is warranted to better understand
the clinical significance, timing, duration, and trajectories of
immune changes that occur following interpersonal loss (22).
Large-scale longitudinal studies that systematically collect data
on mental and physical health outcomes prior to and after
spousal bereavement are needed. This longitudinal approach will
help identify profiles that predict poor responses to the death of a
significant person and thus aid in the identification of people who
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would benefit from personalized interventions and, moreover,
the initial design of such interventions.
Third, studies investigating the biological bases of stress
resilience will be important for elucidating processes that
may help promote psychosocial resilience to interpersonal loss
(203). From the perspective of the Social Signal Transduction
Theory of Depression, vulnerability and resilience arises from a
combination of social-environmental conditions (e.g., abuse or
neglect, interpersonal, or financial difficulties), neurocognitive
processes (e.g., perceptions of threat), social factors (e.g.,
social support), and genetics mechanisms (e.g., regulatory
SNPs). According to this perspective, pre-loss neurocognitive,
immunologic, and genetic functioning are important factors
that help shape how a person is likely to respond to
a significant interpersonal loss. Therefore, future studies
examining psychobiological factors of resilience in bereavement
could benefit from investigating G × E interaction effects by
systematically assessing cumulative lifetime stress exposure (204)
in addition to other predisposing psychosocial and biological
factors that may confer increased vulnerability to the death of a
significant person (38).
Fourth, it will be important to study health behaviors,
such as smoking, diet, sleep, and exercise, which are not
presently accounted for in the Social Signal Transduction
Theory of Depression and that are rarely discussed in
psychobiological models of bereavement. Some research has
shown that bereavement is associated with negative health
behaviors, especially diet and sleep (205, 206), but this literature
is small for a topic that deserves serious attention.
Finally, investigating the interplay between multiple
psychological and biological markers of stress over time involves
substantial analytic computational complexity. Therefore, we
believe that multilevel statistical approaches such as structural
equation modeling and latent growth mixture modeling will
be helpful for characterizing inter-individual differences in
intra-individual changes over time (207).
CONCLUSION
In conclusion, the death of a spouse is considered one of the
most stressful life events a person can experience. In addition
to increasing risk for depression, spousal death can lead to
increased risk for a variety of somatic and physical diseases,
as well as early mortality. Our goal with the present review
was to help make sense out of these effects by reviewing social,
psychological, immunologic, and genetic processes that have
the potential to shape vulnerability to morbidity and mortality
following spousal bereavement. We also related these processes
to the Social Signal Transduction Theory of Depression, which
we believe is one useful, multi-level framework that can be
used to understand how social stressors affect psychobiological
processes that impact health. In terms of future studies, it will
be important to explore the associations described herein to
help identify individuals at high risk for poor health outcomes
following the death of a significant person. This knowledge could
help to elucidate biobehavioral mechanisms that clinicians could
in turn target early after a loss to improve health outcomes in
bereaved spouses. Given the centrality of interpersonal loss to the
human experience, we believe that muchmore research is needed
to understand how exactly spousal bereavement affects health
and howwe can translate this knowledge to increase psychosocial
resilience to such stress.
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